ResMed Inc.
ResMed Inc. Announces Board Changes and Plan Amendments at Annual Meeting
Summary
ResMed Inc. announced at its 2025 Annual Meeting that Richard Sulpizio did not seek re-election, leading to a reduction in the board size from twelve to eleven members. The meeting also resulted in the approval of amendments to the 2009 Incentive Award Plan and the 2018 Employee Stock Purchase Plan by the stockholders. These amendments include increases in the number of shares reserved for issuance and the elimination of fixed terms for the plans.
Profitelligence Alerts
Get alerts for RMD
Be first to know when ResMed Inc. files with the SEC.
Filing Categories
Advertisement
About ResMed Inc.
ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producing advanced equipment for sleep apnea therapy, chronic obstructive pulmonary disease (COPD), and various respiratory conditions. The company's offerings include a range of cutting-edge products like continuous positive airway pressure (CPAP) devices, bilevel systems, and ventilators, designed to enhance patient comfort and compliance. ResMed is also at the forefront of integrating cloud-connected devices to support improved patient monitoring and telemedicine services. The healthcare industry, particularly the medical device sector, benefits significantly from ResMed's contributions, as the company aims to address the growing needs associated with sleep and respiratory conditions. By focusing on both personal and overarching health care solutions, ResMed plays a crucial role in enhancing patient quality of life, thereby solidifying its position as a key player in the global health and respiratory care markets.
Official SEC Documents
Advertisement